Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 46.46MTotal Debt
VS
Market
Sector
Industry
History
$ 14.01Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information
Ticker
TBPHCompany Name
THERAVANCE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTHERAVANCE BIOPHARMA INC - Total Debt Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TBPH - Debt Historical data
| Date | Total Debt |
|---|---|
| 6/30/2025 | $ 46.46M |
| 3/31/2025 | $ 48.16M |
| 12/31/2024 | $ 49.82M |
| 9/30/2024 | $ 44.98M |
| 6/30/2024 | $ 46.66M |
| 3/31/2024 | $ 47.9M |
| 12/31/2023 | $ 49.16M |
| 9/30/2023 | $ 50.83M |
| 6/30/2023 | $ 51.68M |
| 3/31/2023 | $ 51.19M |
Key Performance Insights, Last 5 Years
- THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) Debt stands at $ 668.68M.
- Over the past 5 years, THERAVANCE BIOPHARMA INC's average Debt has been $ 298.42M.
- The median Debt for THERAVANCE BIOPHARMA INC during this period was $ 51.88M
- THERAVANCE BIOPHARMA INC reached its highest Debt over the past 5 years at $ 677.96M.
- The lowest Debt recorded by THERAVANCE BIOPHARMA INC in the same timeframe $ 44.98M
THERAVANCE BIOPHARMA INC's Debt vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt Benchmarks
Similar metrics to Debt:
- Current Debt - [Balance Sheet] The current (short-term) portion of [Debt] includes the formal borrowings that are due within a year; reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Non-Current Debt - [Balance Sheet] The non-current (long-term) portion of [Debt] includes the formal borrowings that are due after the period of one year; reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Debt to Assets Ratio - [Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
- Non-Current Liabilities - [Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
Definition of Total Debt
[Balance Sheet] The total debt is a component of [Liabilities] that represents principle balances held in exchange for interest paid (also know as loans). Includes secured and unsecured bonds issued, commercial paper, notes payable credit facilities, lines of credit, capital lease obligations, operating lease obligations, and convertible notes.TBPH - Total Debt, Last 5 years
$ 44.98M
Minimum
Sep 30, 2024
$ 677.96M
Maximum
Jun 30, 2022
$ 298.42M
Average
$ 51.88M
Median
Debt Benchmark AnalysisMarket
The chart above depicts the distribution of Debt for companies in the Total Stock Market. The average Debt of the companies is $ 181.96M with a standard deviation of $ 275.27M.
The following table provides additional summary stats:
Debt in the Market:
| filtered constituents | 3.18K |
|---|---|
| min | $ 0 |
| max | $ 1.14B |
| average | $ 181.96M |
| median | $ 37.69M |
| std | $ 275.27M |